Search results for "Coronavirus"


 
Results 131 - 140 of about 177 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

Recommendations and research negative on hydroxychloroquine, early testing after exposure

New ACP practice points say not to use chloroquine or hydroxychloroquine alone or in combination with azithromycin for COVID-19 except in trials, and a new study finds that testing for the novel coronavirus is most accurate one to three days after symptom onset.
https://immattersacp.org/weekly/archives/2020/05/19/1.htm
19 May 2020

News on booster doses and omicron, COVID-19 and women's health, outpatient treatments

Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new outpatient treatments were authorized.
https://immattersacp.org/weekly/archives/2022/01/11/1.htm
11 Jan 2022

N95 masks and gowns available from ACP

ACP members can participate in a bulk purchase of N95 masks and gowns, but orders must be received by 3 p.m. on Friday, June 26.
https://immattersacp.org/weekly/archives/2020/06/23/2.htm
23 Jun 2020

N95 masks and gowns available for purchase through ACP

ACP members can participate in a bulk purchase of N95 masks and gowns, but orders must be received by 3 p.m. ET on Monday, Aug. 24.
https://immattersacp.org/weekly/archives/2020/08/18/2.htm
18 Aug 2020

Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions

Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021

New authorization, guidance on vaccines against SARS-CoV-2

The Moderna COVID-19 vaccine was authorized by the FDA and recommended by the CDC, additional guidance was issued on the use of the Pfizer-BioNTech vaccine, and ACP and Annals of Internal Medicine held a forum on encouraging vaccine uptake.
https://immattersacp.org/weekly/archives/2020/12/22/1.htm
22 Dec 2020

Research, regulators consider booster dose of COVID-19 vaccine

FDA advisors recommended boosters for older and high-risk patients. The latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://immattersacp.org/weekly/archives/2021/09/21/1.htm
21 Sep 2021

NIH adds another antibody to recommended treatments, studies look at early cases, racial disparities

Recent COVID-19 news includes a new NIH recommendation and studies of the earliest U.S. cases, an experimental inpatient drug, and potential causes of racial disparities in outcomes.
https://immattersacp.org/weekly/archives/2021/06/22/1.htm
22 Jun 2021

Q&A with ACP's President on COVID-19 vaccines

George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021

Boosters, convalescent plasma, long-term effects, and other COVID-19 news

Government officials announced that they plan to offer booster shots for the mRNA COVID-19 vaccines. Convalescent plasma didn't improve outcomes for high-risk outpatients in a trial, and two studies reported long-term effects of hospitalization for COVID-19.
https://immattersacp.org/weekly/archives/2021/08/24/1.htm
24 Aug 2021

Result Page: Prev   9   10   11   12   13   14   15   16   17   18   Next